UGint Co., Ltd. announced that it expects to receive KRW 10 billion in funding
September 14, 2017
Share
UGint Co., Ltd. (KOSDAQ:A195990) announced a private placement of 5th round of unregistered coupon unguaranteed private convertible bonds for gross proceeds of KRW 10,000,000,000 on September 15, 2017. The bonds will be issued at par. The bonds will be issued to new investor Glowth & Value Fund 5. The bonds carry fixed coupon rate of 2% per annum and yield to maturity of 2%. The bonds will mature on October 18, 2020. The bonds are 100% convertible into 6,422,607 common shares from October 18, 2018 September 18, 2020 at fixed conversion price of KRW 1,557 per share. The transaction has been approved by board of directors of the company. The subscription and payment date of the transaction is October 18, 2017.
Abpro Bio Co., Ltd., formerly Ugint Co., Ltd., is a Korea-based company engaged in machine tools manufacturing. The Company produces and distributes small sized machining centers for notebooks, smart phones, tablet personal computers, mobile phones, base plates, light emitting diode (LED) and light crystal display (LCD) television panels, automobile parts, motorbikes parts and aircraft parts. The Company also engages in original equipment manufacturing business (OEM). The Company operates its business within domestic markets and foreign markets such as China and Europe countries.